AUSTIN DUMBAUGH: Open Payments
NPI 1124777115 · KENTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 29 payments from 12 companies in 2025. Trend: 2023 $157 · 2024 $401 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 8 | $219 |
| ABBVIE INC. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: ZORYVE, CAPLYTA, REXULTI, GEMTESA, UBRELVY, VRAYLAR, XIFAXAN, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
